Ketoprofen Comparative Pharmacokinetics Analysis in Humans and Animals: A Review
Open Access
- 18 December 2025
- journal article
- review article
- Published by SCEEMP in Safety and Risk of Pharmacotherapy
- Vol. 13 (4) , 426-439
Abstract
INTRODUCTION . Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) with pronounced analgesic, anti-inflammatory and antipyretic effect. Ketoprofen pharmacokinetics is comparatively well described in various in vivo models. Since it is potentially possible to create new dosage forms of ketoprofen, with pharmacokinetics studies contributing to high-quality pharmaceutical development, a comparative assessment is relevant for the data on animals and humans. AIM. This study aimed to identify animal species relevant for preclinical studies of different ketoprofen dosage forms by summarising bioanalytical methods used to assess pharmacokinetics and by comparing various test systems. DISCUSSION . Reversed-phase high-performance liquid chromatography with ultraviolet/mass spectrometric detection and acetonitrile or methanol-based eluents in various buffer solutions is the most ubiquitous method for ketoprofen analysis in biomaterials. Ketoprofen pharmacokinetics was studied in humans and animals of several phylogenetic species using various dosage forms (injectable solutions, tablets, paste forms, etc.) and the relevant administration (intravenous, intramuscular, oral, transdermal). High drug bioavailability was noted for different routes. Maximum concentration (C max ) range at similar doses and similar time parameters (time to maximum concentration, T max , half-life, T 1/2 and mean residence time, MRT) for the three main administration routes (oral, intravenous and intramuscular) was comparable in humans and rats, cats, and dogs; thus these test systems were suggested for pharmacokinetics studies of ketoprofen preparations. CONCLUSIONS . The analysis suggested that rats and larger animals (cats, dogs) can serve as test systems in ketoprofen pharmacokinetics studies, at least for oral, intravenous, and intramuscular administration. Using ketoprofen as an example, the study showed feasibility of integrating heterogeneous pharmacokinetic data, as well as comparison challenges due to variable test systems, study objects, dosages, and administration routes.Keywords
This publication has 35 references indexed in Scilit:
- Biocompatible phospholipid‐based nanovesicular drug delivery system of ketoprofen: Systematic development, optimization, and preclinical evaluationBiotechnology and Applied Biochemistry, 2022
- Influence of obesity on pharmacokinetics and analgesic effect of ketoprofen administered intravenously to patients after laparoscopic cholecystectomyPharmacological Reports, 2020
- The pharmacokinetics of oral ketoprofen in patients after gastric resectionPharmacological Reports, 2017
- Pharmacokinetics of ketoprofen enantiomers following intravenous and oral administration to exercised Thoroughbred horsesThe Veterinary Journal, 2016
- Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy SubjectsEuropean Journal of Drug Metabolism and Pharmacokinetics, 2015
- Pharmacokinetics of the individual enantiomer S-(+)-ketoprofen after intravenous and oral administration in dogs at two dose levelsResearch in Veterinary Science, 2014
- Isobolographic analysis of the antinociceptive interactions between ketoprofen and paracetamolEuropean Journal of Pharmacology, 2007
- Pharmacokinetics of ketoprofen following oral and intramuscular administration in young children.European Journal of Clinical Pharmacology, 2001
- Pharmacokinetics of ketoprofen in rats: Effect of age and doseBiopharmaceutics & Drug Disposition, 1992
- The Clinical Pharmacology of KetoprofenThe Journal of Clinical Pharmacology, 1988